Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 2/20 | 0.45 |
| ▸ | PDE4A | P27815 | 7/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 7/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 7/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 7/20 | 0.43 |
| ▸ | MGMT | P16455 | 2/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.39 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.38 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6265343 | 0.87 | PDE4A (0.55) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6267430 | 0.84 | PNP (0.45) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6268093 | 0.84 | ADORA2A (0.42) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL1047660 | 0.84 | PNP (0.45) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL28071828 | 0.84 | PNP (0.45) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6265538 | 0.83 | MGMT (0.47) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL8343189 | 0.81 | PDE4A (0.35) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6266783 | 0.81 | MGMT (0.49) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL27842808 | 0.81 | PDE4A (0.53) | PNPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6271705 | 0.81 | CDK1 (0.52) | PNPPDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110013441-A | For the salicylic aqueous solution of solubilising, preparation method and include its cosmetic composition | 株式会社爱茉莉太平洋 | 2019-07-16 | — | — | CN | claimed |
| EP-0792283-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1996015143-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1996-05-23 | — | — | WO | claimed |
| CN-110013441-A | For the salicylic aqueous solution of solubilising, preparation method and include its cosmetic composition | 株式会社爱茉莉太平洋 | 2019-07-16 | — | — | CN | disclosed |
| CN-107951765-A | Purple bamboo shoot tea extraction and its application | 欧诗漫生物股份有限公司 | 2018-04-24 | — | — | CN | disclosed |
| CN-107530263-A | For reducing the drying time of hair and improving the composition of its pliability | 株式会社爱茉莉太平洋 | 2018-01-02 | — | — | CN | disclosed |
| CN-107427434-A | Promote the composition comprising genistein or Epigallo-catechin gallate (EGCG) of cell rejuvenation for inducing | 株式会社爱茉莉太平洋 | 2017-12-01 | — | — | CN | disclosed |
| CN-107412031-A | Dermatologic preparation composition containing orange peel element | 株式会社爱茉莉太平洋 | 2017-12-01 | — | — | CN | disclosed |
| CN-103222930-B | Composition for external application containing tangeretin and epigallocatechin | 株式会社爱茉莉太平洋 | 2017-08-29 | — | — | CN | disclosed |
| CN-106999527-A | For preventing hair loss or stimulating the composition for including umbel parthenium extract of natural on-off cycles of hair growth | 株式会社爱茉莉太平洋 | 2017-08-01 | — | — | CN | disclosed |
| CN-106999528-A | For preventing hair loss or stimulating the composition for including high mountain radix scutellariae extract of natural on-off cycles of hair growth | 株式会社爱茉莉太平洋 | 2017-08-01 | — | — | CN | disclosed |
| CN-103889397-B | Cosmetic composition containing green tea component | 株式会社爱茉莉太平洋 | 2017-05-10 | — | — | CN | disclosed |
| EP-1873156-A1 | Process for the preparation of 6-[[(alkoxy)carbonyl]amino]-9H-Purine-9-acetic acid and 4-[(alkoxycarbonyl)amino]-2-oxo-1(2H)-Pyrimidineacetic acid derivatives as synthons for the synthesis of peptide nucleic acids | PerSeptive Biosystems, Inc. (US) | 2008-01-02 | — | — | EP | disclosed |
| EP-0736027-B1 | GUANINE SYNTHONS FOR PEPTIDE NUCLEIC ACID SYNTHESIS AND METHOD FOR PRODUCTION | PERSEPTIVE BIOSYSTEMS INC (US) | 2002-05-29 | — | — | EP | disclosed |
| US-6172226-B1 | Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions | PERSEPTIVE BIOSYSTEMS, INC. | 2001-01-09 | — | — | US | disclosed |
| US-6133444-A | PURINE PEPTIDE NUCLEIC ACIDS SYNTHONS | PERSEPTIVE BIOSYSTEMS, INC. (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0840736-A1 | IMPROVED SYNTHONS FOR THE SYNTHESIS AND DEPROTECTION OF PEPTIDE NUCLEIC ACIDS UNDER MILD CONDITIONS | PerSeptive Biosystems, Inc. (US) | 1998-05-13 | — | — | EP | disclosed |
| WO-1996040685-A1 | IMPROVED SYNTHONS FOR THE SYNTHESIS AND DEPROTECTION OF PEPTIDE NUCLEIC ACIDS UNDER MILD CONDITIONS | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0736027-A1 | GUANINE SYNTHONS FOR PEPTIDE NUCLEIC ACID SYNTHESIS AND METHOD FOR PRODUCTION | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1996-10-09 | — | — | EP | disclosed |
| WO-1995017403-A1 | GUANINE SYNTHONS FOR PEPTIDE NUCLEIC ACID SYNTHESIS AND METHOD FOR PRODUCTION | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1995-06-29 | — | — | WO | disclosed |